Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 3, 2002, Pages 375-382

  Tumbarello, Mario ^a   de Gaetano Donati, Katleen ^a   Tacconelli, Evelina ^a   Citton, Rita ^a   Spanu, Teresa ^a   Leone, Fiammetta ^a   Fadda, Giovanni ^a   Cauda, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; MACROLIDE; METICILLIN; OXACILLIN; PENICILLIN G; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADULT; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HELPER CELL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; VIREMIA;

EID: 0036735267     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf126     Document Type: Article

References (46)

1. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus
2. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients
3. Bacteremia in persons with HIV infection
4. The impact of bacteremia on HIV infection. Nine years experience in a large Italian university hospital
5. Bacteremia in hospitalized patients infected with HIV; a case control study of risk factors and outcome
6. Bacteremia in HIV-infected patients: Short-term predictors of mortality
7. Nosocomial bloodstream infections in HIV-infected patients: Attributable mortality and extension of hospital stay
8. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome
9. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infections
10. HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era
11. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia
12. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus?
13. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence
14. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus in a university hospital
15. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains
16. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
17. Staphylococcus aureus bacteremia: Factors predicting hospital mortality
18. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
19. Risk factors for mortality in Staphylococcus aureus bacteremia
20. Outbreak among HIV-infected patients of Staphylococcus aureus resistant to cotrimoxazole and methicillin
21. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: A retrospective case-control study
22. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-seropositive persons
23. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalised adults
24. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs?
25. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: Is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?
26. Methicillin-resistant Staphylococcus aureus in the community: A hospital-based study
27. Methicillin-resistant Staphylococcus aureus in the community: New battlefronts, or are the battles lost?
28. Hospital and community-based surveillance of methicillin-resistant Staphylococcus aureus: Previous hospitalization is the major risk factor
29. True community-acquired methicillin-resistant Staphyloccus aureus bacteremia
30. Methicillin-resistant Staphylococcus aureus in Europe
31. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study
32. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
33. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
34. Methicillin and glycopeptide resistance in staphylococci: A new threat?
35. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital
36. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
37. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
38. First clinical isolate of vancomycin-intermediate S. aureus in a French hospital
39. Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus
40. Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection
41. Assessment of the relationship between antimicrobial usage and susceptibility: Difference between the hospital and specific patient-care areas
42. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary
43. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia
44. Revised guidelines for control of MRSA: Applying appropriately-based recommendations